ABOPM Seal
Donate Today Log In
Meet the Visionaries Leading the Future of Precision Medicine
Executive Team
At the American Board of Precision Medicine (ABOPM), our executive team brings together pioneers in science, healthcare, education, and technology. With decades of combined experience and a shared commitment to innovation, these leaders are shaping the strategic direction of ABOPM — driving our mission to advance multi-omics, systems biology, and personalized care for a healthier world.
Executive Leadership

The Visionaries Powering ABOPM

Guiding the future of precision medicine through clinical excellence, education, genomics, AI innovation, and global health leadership.

Co-Founder | Chief Medical Officer

Matthew D. Taylor, MD, DABFM, FMCP-M

Dr. Matthew Taylor is a board-certified family physician and a leading practitioner of P4 precision medicine, known for mentoring physicians in integrative and personalized medicine internationally.

Read More

He earned his medical degree from Wayne State University School of Medicine and completed family medicine training at UPMC Altoona and the University of Maryland Medical Center.

His continuing education spans numerous advanced programs including the National Lipidology Association, SSRP Cellular Medicine Fellowship, the Institute for Functional Medicine, Trauma Research Foundation, NICABM, and the International Society for Environmentally Acquired Illness.

As co-founder of the American Board of Precision Medicine, he contributes clinical leadership and strategic insight to the organization’s educational initiatives and physician training programs.

LinkedIn
Chief Technology Officer | Chief Medical Officer

Dr. Puya Yazdi, MD

Dr. Yazdi is a physician-scientist and entrepreneur specializing in genomics, bioinformatics, and AI-driven precision medicine innovation.

Read More

He completed medical training at USC and residency at Stanford University and later became a Clinical Fellow in regenerative medicine at UC Irvine.

As founder of Systomic Health and leader at SelfDecode, he has pioneered genomic technologies used by biotechnology companies and global health platforms.

His work focuses on translating advanced genomic science into scalable healthcare solutions worldwide.

LinkedIn
Chief Strategy Officer

Ralph Kenney

Ralph Kenney is a senior executive specializing in health technology, strategic growth, and AI-driven precision health platforms.

Read More

As COO and CFO of SelfDecode he built a B2B division generating over $100M in contracts and helped expand the company’s genomics platform worldwide.

Previously he served as COO of R Systems Inc., scaling operations dramatically and leading the company through a successful IPO.

Earlier leadership roles at AT&T involved managing business units with more than $150M in annual revenue.

LinkedIn
Multi-Omics Science

The Role of Multi-Omics in Precision Medicine

Modern medicine increasingly recognizes that disease is driven by complex biological interactions rather than single genetic or molecular abnormalities. Multi-omics science integrates multiple biological layers to provide a comprehensive molecular understanding of health and disease.

Genomics

Genomics – The study of DNA and genetic variation that influences disease risk and treatment response.

Explore
Transcriptomics

Transcriptomics – Analysis of gene expression patterns that reveal how cells respond to disease processes.

Explore
Proteomics

Proteomics – Investigation of protein structures and interactions that drive biological function.

Explore
Metabolomics

Metabolomics – Measurement of metabolic pathways that reflect cellular activity and disease states.

Explore
Microbiomics

Microbiomics – Understanding the role of the human microbiome in immune regulation, metabolism, and chronic disease.

Explore
Featured Insights

Insights Shaping
Precision Medicine

Explore ABOPM perspectives on genomics, multi-omics, systems thinking, clinical innovation, and the future of physician leadership in precision medicine.

Multi-Omics Clinical Innovation Precision Prevention Physician Leadership
Pharmacogenomics in Clinical Practice: Prescribing the Right Drug the First Time

Pharmacogenomics in Clinical Practice: Prescribing the Right Drug the First Time

Helping clinicians understand how genetic variation influences drug response ...more

Precision Medicine in Action

May 13, 20269 min read

Tumor Genomic Profiling: When Should It Be Used in Clinical Practice?

Tumor Genomic Profiling: When Should It Be Used in Clinical Practice?

Tumor genomic profiling helps identify actionable mutations to guide targeted therapies and clinical decisions. Understanding when to use it is key to maximizing its impact in precision oncology. ...more

Precision Oncology

May 07, 20268 min read

Why Diversity in Genomic Research Matters for Precision Medicine

Why Diversity in Genomic Research Matters for Precision Medicine

Genomic diversity is essential for accurate, equitable precision medicine. Expanding representation in research improves risk prediction, variant interpretation, and ensures better outcomes for all po... ...more

Population Precision

April 23, 20268 min read

Advancing education, certification, and leadership to shape a genomics-driven, data-intelligent future of healthcare.

2810 N Church St., PMB 364141
Wilmington, Delaware 19802-4447 US

+1 (954) 944-2717


© 2023-2025 American Board of Precision Medicine, Inc. All Rights Reserved.